A phase I trial of intranasal peptide T: safety, toxicity, and pharmacokinetics in human immunodeficiency virus-1 (HIV-1) infected patients.
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2015
At a glance
- Drugs Peptide T (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 22 Nov 2005 New trial record.